Status epilepticus

CONTINUUM Lifelong Learning in Neurology

Volumn 21, Issue 5, 2015, Pages 1362-1383

  Hocker, Sara E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; KETAMINE; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL; VALPROIC ACID;

ACIDOSIS; ACUTE KIDNEY TUBULE NECROSIS; ANTICONVULSANT THERAPY; ARTIFICIAL VENTILATION; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; EPILEPTIC STATE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; HYPOXEMIA; LIVER TOXICITY; LUNG EDEMA; METABOLIC ACIDOSIS; MUSCULOSKELETAL INJURY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROPOFOL INFUSION SYNDROME; RECOMMENDED DRUG DOSE; REVIEW; RHABDOMYOLYSIS; TAKOTSUBO CARDIOMYOPATHY; DISEASE MANAGEMENT; STATUS EPILEPTICUS;

DISEASE MANAGEMENT; HUMANS; PRACTICE GUIDELINES AS TOPIC; STATUS EPILEPTICUS;

EID: 84977765526     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/CON.0000000000000225     Document Type: Review

References (48)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures: from the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22(4):489-501.
2. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338(14):970-976. doi:10.1056/NEJM199804023381407.
3. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010;17(3): 348-355. doi:10.1111/j.1468-1331.2009.02917.x.
4. Brophy GM, Bell R, Claassen J, et al; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17(1):3-23. doi:10.1007/s12028-012-9695-z.
5. Freilich ER, Schreiber JM, Zelleke T, Gaillard WD. Pediatric status epilepticus: identification and evaluation. CurrOpin Pediatr 2014;26(6):655-661. doi:10.1097/MOP.0000000000000152.
6. Abend NS, Loddenkemper T. Pediatric status epilepticus management. Curr Opin Pediatr 2014;26(6):668-674. doi:10.1097/MOP.0000000000000154.
7. Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist 2005;11(6):348-361.
8. Avbersek A, Sisodiya S. Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures? J Neurol Neurosurg Psychiatry 2010;81(7):719-725. doi:10.1136/jnnp.2009.197996.
9. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 1997;17(19):7532-7540.
10. Naylor DE, Liu H, Niquet J, Wasterlain CG. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol Dis 2013;54:225-238. doi:10.1016/j.nbd.2012.12.015.
11. Cock HR, Tong X, Hargreaves I, et al. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res 2002;48(3):157-168. doi:10.1016/S0920-1211(01)00334-5.
12. David Y, Cacheaux LP, Ivens S, et al. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J Neurosci 2009;29(34):10588-10599. doi:10.1523/JNEUROSCI.2323-09.2009.
13. Friedman A, Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 2011;52(suppl 3):33-39. doi:10.1111/j.1528-1167.2011.03034.x.
14. Marchi N, Granata T, Freri E, et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 2011;28(3):e18200. doi:10.1371/journal.pone.0018200.
15. De Lorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46(4): 1029-1035. doi:10.1212/WNL.46.4.1029.
16. Hesdorffer DC, Logroscino G, Cascino G, et al. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998;50(3):735-741. doi:10.1212/WNL.50.3.735.
17. Waterhouse EJ, Garnett LK, Towne AR, et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 1999;40(6):752-758. doi:10.1111/j. 1528-1157.1999.tb00774.x.
18. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59(2): 205-210. doi:10.1001/archneur.59.2.205.
19. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005;76(4):534-539. doi:10.1136/jnnp.2004.041947.
20. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005;62(11):1698-1702. doi:10.1001/archneur.62.11.1698.
21. Logroscino G, Hesdorffer DC, Cascino G, et al. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997;38(12):1344-1349. doi:10.1111/j. 1528-1157.1997.tb00073.x.
22. Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care 2014;20(3):476-483. doi:10.1007/s12028-013-9935-x.
23. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43(2): 146-153. doi:10.1046/j.1528-1157.2002.28501.x.
24. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia 2010;51(2):251-256. doi:10.1111/j.1528-1167.2009.02323.x.
25. Hocker SE, Britton JW, Mandrekar JN, et al. Predictors of outcome in refractory status epilepticus. JAMA Neurol 2013;70(1):72-77. doi:10.1001/jamaneurol.2013.578.
26. Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014;82(8):656-664. doi:10.1212/WNL.0000000000000009.
27. Alroughani R, Javidan M, Qasem A, Alotaibi N. Non-convulsive status epilepticus; the rate of occurrence in a general hospital. Seizure 2009;18(1):38-42. doi:10.1016/j.seizure. 2008.06.013.
28. Veran O, Kahane P, Thomas P, et al. De novo epileptic confusion in the elderly: a 1-year prospective study. Epilepsia 2010; 51(6):1030-1035. doi:10.1111/j.1528-1167. 2009.02410.x.
29. Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res 2010;91(2-3):111-122. doi:10.1016/j.eplepsyres.2010.07.015.
30. Huff JS, Fountain NB. Pathophysiology and definitions of seizures and status epilepticus. Emerg Med Clin North Am 2011;29(1):1-13. doi:10.1016/j.emc.2010.08.001.
31. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996;47(1):83-89.
32. Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol 2005;22(2):79-91.
33. McKeon A. Hot topics: evaluating autoimmune encephalopathies, dementias, and epilepsies. Mayo Medical Laboratories. www.mayomedicallaboratories.com/articles/hot-topic/2014/08-01-evaluating-autoimmune-encephalopathies-dementias-epilepsies/index.html. Published August 2014. Accessed July 31, 2015.
34. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339(12):792-798. doi:10.1056/NEJM199809173391202.
35. Aranda A, Foucart G, Ducasse JL, et al. Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia 2010;51(10):2159-2167. doi:10.1111/j.1528-1167.2010.02688.x.
36. Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry 2001;70(suppl 2):II22-II27. doi:10.1136/jnnp.70.suppl-2.ii22.
37. Chen JW, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006;5(3):246-256. doi:10.1016/S1474-4422(06)70374-X.
38. Claassen J, Silbergeit R. Status epilepticus. enlsprotocols.org/flash/flash.html. Accessed April 23, 2015.
39. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345(9):631-637. doi:10.1056/NEJMoa002141.
40. Silbergleit R, Durkalski V, Lowenstein D, et al; NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591-600. doi:10.1056/NEJMoa1107494.
41. Cascino GD, Hesdorffer D, Logroscino G, Hauser WA. Treatment of nonfebrile status epilepticus in Rochester, Minn, from 1965 through 1984. Mayo Clin Proc 2001; 76(1):39-41. doi:10.4065/76.1.39.
42. Bleck T, Cock H, Chamberlain J, et al. The established status epilepticus trial 2013. Epilepsia 2013;54(suppl 6):89-92. doi:10.1111/epi.12288.
43. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006;67(2):340-342. doi:10.1212/01.wnl.0000224880.35053.26.
44. Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16(6):527-532. doi:10.1016/j.seizure.2007.04.012.
45. Hocker S, Tatum WO, La Roche S, Freeman WD. Refractory and super-refractory status epilepticus-an update. Curr Neurol Neurosci Rep 2014;14(6):452. doi:10.1007/s11910-014-0452-x.
46. Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013;54(8):1498-1503. doi:10.1111/epi.12247.
47. Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014;82(8):665-670. doi:10.1212/WNL.0000000000000151.
48. Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012;40(9):2677-2684. doi:10.1097/CCM.0b013e3182591ff1.